Frontlight ResearchEarly access
Metastatic breast cancer trials in United States
222 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleA Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
- Where
- Aurora, Birmingham, Boston, Buffalo, Fort Worth, Fullerton, Greenbrae, La Jolla, Lebanon, New Hyde Park, Newport Beach, New York, San Antonio, St Louis
- Age
- 18 years and over
- People
- 234 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06997029 · EU 2025-524334-26-01 - No phaseNot yet taking people in United StatesBlood Biomarkers for Breast Cancer Treatment Response
- Where
- Pittsburgh
- Age
- 18 years and over
- People
- 200
- Run by
- University of Pittsburgh
See details and how to joinNCT07860866 - Phase 1/2Taking peopleStudy of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
- Where
- Boston, Chicago, Houston, La Jolla, Los Angeles, New York, Portland, Richmond, San Antonio, San Francisco
- Age
- 18 years to 130 years
- People
- 695 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05417594 · EU 2023-504984-17-00 - Phase 1Taking peoplePhase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
- Where
- Aurora, Boston, Columbus, Gilbert, Grand Rapids, Nashville, New Orleans, New York, San Antonio, Sarasota, West Valley City
- Age
- 18 years and over
- People
- 180 worldwide
- Run by
- Olema Pharmaceuticals, Inc.
See details and how to joinNCT06784193 - Phase 2Taking peopleA Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer
- Where
- Allentown, Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Uniondale
- Age
- 18 years and over
- People
- 46
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT05534438 - Phase 3Taking peopleA Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer
- Where
- Fort Wayne, Houston, Largo, New York, Omaha, Puyallup
- Age
- 18 years and over
- People
- 100 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07205822 · EU 2025-521904-23-00 - Phase 2Taking peopleA Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
- Where
- Atlanta, Aurora, Beverly Hills, Birmingham, Boston, Chapel Hill, Chicago, Columbia, Columbus, Dallas, Fountain Valley, Horsham, Irvine, Jacksonville, Kansas City, Los Angeles, Maumee, Minneapolis, Nashville, New Haven, Philadelphia, Phoenix, Pittsburgh, Reno, Richmond, Rochester, San Francisco, Springfield, St Louis, Tampa
- Age
- 18 years and over
- People
- 225 worldwide
- Run by
- Puma Biotechnology, Inc.
See details and how to joinNCT06369285 · EU 2024-511497-79-00 - Phase 1Taking peopleOpen-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- Where
- Boston, Dallas, Duarte, Houston, Indianapolis, Kansas City, Los Angeles, Madison, Nashville, New York, San Antonio, San Diego, San Francisco, Seattle, St Louis, Tampa
- Age
- 18 years and over
- People
- 392 worldwide
- Run by
- TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
See details and how to joinNCT06625775 · EU 2024-519445-29-00 - Phase 1/2Taking peopleA Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer
- Where
- Aurora, Boston, Dallas, Los Angeles, Memphis, Nashville, New Haven, New York, Norfolk, Portland, Stanford
- Age
- 18 years and over
- People
- 220 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT07701941 · EU 2024-517541-14-00 - No phaseNot yet taking people in United StatesFit2ThriveMB: Optimization of a Physical Activity Promotion Intervention for Metastatic Breast Cancer Patients
- Where
- Chicago
- Age
- 18 years and over
- People
- 224
- Run by
- Northwestern University
See details and how to joinNCT07840599 - Phase 1/2Taking peoplePRE-ISPY Phase I/II Oncology Platform Program
- Where
- Aurora, Birmingham, Chicago, Houston, Minneapolis, New Lenox, Orland Park, Phoenix, Rochester, Tampa
- Age
- 18 years and over
- People
- 280
- Run by
- QuantumLeap Healthcare Collaborative
See details and how to joinNCT05868226 - Phase 2Taking peoplePhase II Single Arm Trial of Low Dose Capecitabine in Patients With Advanced Breast Cancer
- Where
- Birmingham
- Age
- 60 years and over
- People
- 40
- Run by
- University of Alabama at Birmingham
See details and how to joinNCT06105684 - Phase 2Taking peopleStudy to Evaluate the Safety and Tolerability of Camizestrant in Combination With Atirmociclib in Women With Advanced Breast Cancer
- Where
- East Providence, Nashville, St Louis
- Age
- 18 years and over
- People
- 24 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07427394 - Phase 1/2Taking peopleSRS & Abemaciclib w/wo Imlunestrant in the Management of HR+/HER2- Breast CA Brain Metastases
- Where
- Columbus, Tampa
- Age
- 18 years and over
- People
- 31
- Run by
- H. Lee Moffitt Cancer Center and Research Institute
See details and how to joinNCT04923542 - No phaseTaking peopleEvaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians
- Where
- Chapel Hill
- People
- 15
- Run by
- UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT05440929 - Phase 1/2Taking peopleStudy of AVZO-021 in Patients With Advanced Solid Tumors
- Where
- Cleveland, Dallas, Fairfax, Mineola, New Haven, New York, Oklahoma City, Philadelphia, Portland, Sarasota, Tampa
- Age
- 18 years and over
- People
- 430 worldwide
- Run by
- Avenzo Therapeutics, Inc.
See details and how to joinNCT05867251 - No phaseTaking peopleGroup-based Comprehensive Lifestyle Program for Women With Metastatic Breast Cancer
- Where
- Houston
- Age
- 18 years and over
- People
- 100
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07179809 - Phase 2Taking peopleFunctional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
- Where
- Chapel Hill, Seattle, St Louis
- Age
- 18 years and over
- People
- 60
- Run by
- University of Washington
See details and how to joinNCT06179303 - Phase 1Taking peopleTRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast Cancer
- Where
- Houston
- Age
- 18 years to 80 years
- People
- 27
- Run by
- Baylor College of Medicine
See details and how to joinNCT06251544 - Phase 1Taking peopleAn Optimized Ultrasound Twinkling Marker for the Imaging of Lymph Nodes in Patients With Clinically Node-Positive Breast Cancer, The UTMOST2 Trial
- Where
- Rochester
- Age
- 18 years and over
- People
- 20
- Run by
- Mayo Clinic
See details and how to joinNCT06999798 - Phase 3Taking peoplePalazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
- Where
- Ames, Annapolis, Ann Arbor, Aurora, Baltimore, Bartlett, Beverly Hills, Burlington, Catonsville, Charlotte, Cincinnati, Columbus, Dallas, Denton, Denver, Durham, El Paso, Fort Belvoir, Honolulu, Horsham, Hot Springs, Houston, Jackson, Kansas City, Knoxville, La Jolla, Lebanon, Los Alamitos, Marietta, Midlothian, Milwaukee, Minneapolis, Mount Juliet, Nashville, New Haven, New York, Norfolk, Oakland, Olympia, Peoria, Portland, Roseville, Salt Lake City, San Antonio, San Francisco, Santa Barbara, Santa Clara, Santa Fe, Sayre, Scarborough, Seattle, Tampa, Tennessee City, Urbana, Vallejo, Vancouver, Walnut Creek
- Age
- 18 years and over
- People
- 1,000 worldwide
- Run by
- Olema Pharmaceuticals, Inc.
See details and how to joinNCT07085767 · EU 2025-522873-12-00 - Phase 2Taking peopleEvolutionary Clinical Trial for Novel Biomarker-Driven Therapies
- Where
- Baltimore, Chapel Hill, Houston, New Haven, Philadelphia, Rochester
- Age
- 18 years and over
- People
- 700
- Run by
- UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT07340541 - No phaseTaking peoplePulsed Electric Field Ablation for Metastatic Breast Cancer
- Where
- San Francisco
- Age
- 18 years and over
- People
- 20
- Run by
- University of California, San Francisco
See details and how to joinNCT07487844 - Phase 2Taking peopleStudy of Screening Brain MRIs in Stage IV Breast Cancer
- Where
- Clearwater, Tampa
- Age
- 18 years and over
- People
- 170
- Run by
- H. Lee Moffitt Cancer Center and Research Institute
See details and how to joinNCT05115474 - Phase 2Taking peopleOlaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer
- Where
- Houston
- Age
- 18 years and over
- People
- 60
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT04090567